Clarivate Plc has released the Top 100 Global Innovators™ 2022 list. Drawing on Clarivate™ data, the annual list identifies the organizations that demonstrate consistent, above-the-bar innovation excellence and which sit at the very top of the global innovation ecosystem.
As it relates to pharma and medtech, three companies in those industries have been identified in this year’s top 100 list, including:
The pharmaceuticals sector remains represented in the Top 100 Global Innovators 2022, but perhaps at a lower level than in previous years. This sector’s success in delivering vast improvement in human health, highlighted so importantly during the last 2 years, is partially due to the very high level of collaboration and partnership the sector has evolved into over the past two decades.
Read more about the full report here.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.